Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business
  • Functional Area Sort ascending
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Functional Area Sort ascending Erscheinungsdatum
Associate Director DDIT ISC CSOC Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 30, 2024
Associate Director AWS D&A Platform Analytics Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 30, 2024
Head DDIT OPX Global Initiatives Prague Tschechische Republik Operations CTS Technology Transformation Sep 30, 2024
Associate Director Enterprise Architect -IAM Barcelona Gran Vía Spanien Operations CTS Technology Transformation Sep 04, 2024
Associate Director OPX Planning Prague Tschechische Republik Operations CTS Technology Transformation Sep 06, 2024
Business process expert - Life Sciences(Regulatory, CSR, PV) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 09, 2024
Associate Director – Conferencing Platform Services INSURGENTES Mexiko Operations CTS Technology Transformation Sep 09, 2024
Associate Director for Information Security and Compliance, M&A Team Prague Tschechische Republik Operations CTS Technology Transformation Aug 20, 2024
Assoc. Dir. DDIT Dev. Business Analyst, Global Clinical Operations Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 21, 2024
Associate Director, Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 22, 2024
Sr Specialist DDIT IM JP & APMA Soln Int Selangor Malaysia Operations CTS Technology Transformation Aug 22, 2024
Associate Director, Veeva CRM Architect Barcelona Gran Vía Spanien Operations CTS Technology Transformation Sep 03, 2024
Microsoft 365 Solution Architect Prague Tschechische Republik Operations CTS Technology Transformation Mai 16, 2024
Sr. Spec. DDIT ISC IES Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 21, 2024
Senior Specialist, Master Batch Record (MBR) Design Indianapolis USA Operations CTS Technology Transformation Mai 28, 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 29, 2024
S/4HANA ABAP Technical Expert INSURGENTES Mexiko Operations CTS Technology Transformation Sep 03, 2024
Enterprise Architecture and Integration Director for Commercial Areas INSURGENTES Mexiko Operations CTS Technology Transformation Jun 04, 2024
Assoc. Dir. DDIT APD ERP Commercials and Cross Functional Santo Amaro Brasilien Operations CTS Technology Transformation Sep 03, 2024
Senior Security Architect - Commercial areas INSURGENTES Mexiko Operations CTS Technology Transformation Jun 19, 2024
Associate Director - IT Project/Program Manager Prague Tschechische Republik Operations CTS Technology Transformation Sep 03, 2024
Network Security Engineer - Firewall Services INSURGENTES Mexiko Operations CTS Technology Transformation Jun 25, 2024
Agile Project Management Lead Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Technology Transformation Jul 01, 2024
Junior Engineer - Conferencing (AR / VR platforms) Prague Tschechische Republik Operations CTS Technology Transformation Jul 22, 2024
Associate Director - Cloud Security Architect Prague Tschechische Republik Operations CTS Technology Transformation Jul 23, 2024
LDC IT Planning Manager Prague Tschechische Republik Operations CTS Technology Transformation Sep 03, 2024
Project Manager Selangor Malaysia Operations CTS Technology Transformation Sep 03, 2024
Višji specialist proizvodno informacijskih sistemov / Senior Specialist IT MES Ljubljana Slowenien Operations CTS Technology Transformation Sep 03, 2024
Sr. Manager DDIT GF Sol.Del. China Shanghai (Shanghai) China Operations CTS Technology Transformation Sep 03, 2024
Associate Director OPX Portfolio Management (CZ, Spain, India) Prague Tschechische Republik Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. DDIT OPX Planning Prague Tschechische Republik Operations CTS Technology Transformation Apr 29, 2024
Snr Spec. DDIT US&I D&A Operations Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 30, 2024
Sr Specialist, MDM Operations Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 06, 2024
Sr. Spec. DDIT ISC SecOps Cyber Tools Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 07, 2024
Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 07, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 09, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 09, 2024
Assoc. Dir. DDIT APD ERP PlatformTech Se Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 09, 2024
Snr. Spec. DDIT ISC IES Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 14, 2024
IT Business Partner Director for Clinical Development Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 17, 2024
Sr Principal Observability Engineer Hyderabad (Office) Indien Biomedical Research Pharma Research Technology Transformation Okt 17, 2024
Senior Specialist DDIT ISC Detection & Response Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 17, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 17, 2024
Sr.Spec.DDIT ISC Gov Indep.Control Asses Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 18, 2024
Sr. Spec. DDIT IES DB & MW Services-IES- Cloud Platform Svcs Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 19, 2024
Container Solutions Senior Engineer INSURGENTES Mexiko Operations CTS Technology Transformation Sep 19, 2024
Assoc. Dir. DDIT ISC Gov SOX IT Testing Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 20, 2024
Sr. Spec. DDIT ISC Gov SOX IT Method Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 20, 2024
Associate Director, IT Project Manager, M&A Prague Tschechische Republik Operations CTS Technology Transformation Sep 23, 2024
Associate Director, SUSE Linux Administrator Prague Tschechische Republik Operations Corporate Technology Transformation Sep 23, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.